[Assessment and control of metabolic and cardiovascular risk in patients with schizophrenia].
Rodríguez-Artalejo
Fernando
F
Departamento de Medicina Preventiva y Salud Pública, Universidad Autónoma de Madrid, Arzobispo Morcillo s/n, 2829 Madrid, Spain. fernando.artalejo@uam.es
Baca
Enrique
E
Esmatjes
Enrique
E
Merino-Torres
Juan Francisco
JF
Monereo
Susana
S
Moreno
Basilio
B
Mories
Teresa
T
Roca
Miquel
M
Salvador
Javier
J
Sanmartí
Anna
A
D014150:Antipsychotic Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D008659:Metabolic Diseases / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D012307:Risk Factors; D012559:Schizophrenia / Q000150:complications*
D014150:Antipsychotic Agents